These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 5467681)
21. An effective therapeutic method for the LSD user. Torda C Percept Mot Skills; 1970 Feb; 30(1):79-88. PubMed ID: 5476127 [No Abstract] [Full Text] [Related]
23. LSD and chromosomes. A controlled experiment. Tjio JH; Pahnke WN; Kurland AA JAMA; 1969 Nov; 210(5):849-56. PubMed ID: 4899122 [No Abstract] [Full Text] [Related]
24. [Genetic damage due to LSD? In vivo study of 11-LSD abusers]. Obe G; Herha J Fortschr Med; 1973 Apr; 91(12):533-6. PubMed ID: 4702402 [No Abstract] [Full Text] [Related]
25. [Use of lysergic acid diethylamide in psychoneuroses; preliminary observations and principles of diagnostic and therapeutic evaluation]. GIBERTI F; GREGORETTI L; BOERI G Sist Nerv; 1956; 8(4):191-208. PubMed ID: 13409036 [No Abstract] [Full Text] [Related]
26. [Modern psychiatry. Some fields of activity and research]. Jorgensen F Nord Med; 1968 May; 79(18):577-81. PubMed ID: 5657642 [No Abstract] [Full Text] [Related]
28. A controlled study of LSD treatment in alcoholism and neurosis. Denson R; Sydiaha D Br J Psychiatry; 1970 Apr; 116(533):443-5. PubMed ID: 4392561 [No Abstract] [Full Text] [Related]
29. Chromosome aberrations and LSD. A controlled study in 50 psychiatric patients. Robinson JT; Chitham RG; Greenwood RM; Taylor JW Br J Psychiatry; 1974 Sep; 125(0):238-44. PubMed ID: 4422173 [No Abstract] [Full Text] [Related]
30. A new adjunct to the treatment of alcoholism: the hallucinogenic drugs. SMITH CM Q J Stud Alcohol; 1958 Sep; 19(3):406-17. PubMed ID: 13579169 [No Abstract] [Full Text] [Related]
31. The hallucinogenic drugs--their use and abuse. Whitaker LH Med J Aust; 1968 Mar; 1(9):370-1. PubMed ID: 5646708 [No Abstract] [Full Text] [Related]
32. [The "miracle drug" LSD and its abuse]. Leuner H Landarzt; 1968 Aug; 44(23):1107-16. PubMed ID: 5702787 [No Abstract] [Full Text] [Related]
33. THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS. Alnaes R Acta Psychiatr Scand; 1964; 39(S180):397-409. PubMed ID: 14345225 [No Abstract] [Full Text] [Related]
34. The "bad trip"--the etiology of the adverse LSD reaction. Ungerleider JT; Fisher DD; Fuller M; Caldwell A Am J Psychiatry; 1968 May; 124(11):1483-90. PubMed ID: 4384739 [No Abstract] [Full Text] [Related]
35. Reports of wives of alcoholics of effects of LSD-25 treatment of their husbands. Sarett M; Cheek F; Osmond H Arch Gen Psychiatry; 1966 Feb; 14(2):171-8. PubMed ID: 5948087 [No Abstract] [Full Text] [Related]
36. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Beutler BD; Shinozuka K; Tabaac BJ; Arenas A; Cherian K; Evans VD; Fasano C; Muir OS Am J Ther; 2024 Mar-Apr 01; 31(2):e104-e111. PubMed ID: 38518267 [TBL] [Abstract][Full Text] [Related]
37. LSD-assisted psychotherapy with terminal cancer patients. Pahnke WN; Kurland AA; Goodman LE; Richards WA Curr Psychiatr Ther; 1969; 9():144-52. PubMed ID: 5348915 [No Abstract] [Full Text] [Related]
38. Lysergide therapy and the mauve factor. Denson R Acta Psychiatr Scand; 1968; 44(3):280-8. PubMed ID: 5722604 [No Abstract] [Full Text] [Related]
39. [Undesirable side effects of LSD administration]. Panhuysen LH Ned Tijdschr Geneeskd; 1970 Apr; 114(17):723-7. PubMed ID: 4910547 [No Abstract] [Full Text] [Related]
40. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide. Smith DE; Raswyck GE; Davidson LD J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]